Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment ...
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...
Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.
[19] As for the other nonprimary outcome measures, perindopril did show some benefit in improving NYHA class, decreasing heart failure hospital admission at 1 year, and increasing the 6-minute ...
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...
News Medical on MSN12d
Cardiac damage framework may identify patients who could benefit from earlier TAVRFindings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...
Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR ...
In this underpowered trial, using CMR to guide AVR timing did not nudge the primary endpoint, but did trim AS ...
MitrAssist Lifesciences, a leader in innovative cardiovascular medical devices, today unveiled the initial clinical results ...
Congestion is a common symptom of heart failure in adults, and the associated fluid build ... FUROSCIX can be used to treat these patients regardless of New York Heart Association (NYHA) functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback